Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients

Immunomodulation contributes to the antitumor efficacy of the fractionated radiation therapy (RT). Here, we describe immune effects of RT with concurrent systemic cisplatin or cetuximab treatment of patients with stage III-IV head and neck squamous cell carcinoma (HNSCC). Using longitudinally collec...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampath, Sagus, Won, Haejung, Massarelli, Erminia, Li, Min, Frankel, Paul, Vora, Nayana, Vora, Lalit, Maghami, Ellie, Kortylewski, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834279/
https://www.ncbi.nlm.nih.gov/pubmed/29541413
http://dx.doi.org/10.18632/oncotarget.24397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834279/
https://www.ncbi.nlm.nih.gov/pubmed/29541413
http://dx.doi.org/10.18632/oncotarget.24397

Ejemplares similares